FDA approves drug risk in all heart patients

Written by Washington Vascular Specialists

Established in 2005, Washington Vascular Specialists is the first outpatient vascular treatment center in the mid-Atlantic region and has locations in Takoma Park, Largo, and Frederick, Maryland.



News



February 24, 2022

Feb 24 (Reuters) – The U.S. Food and Drug Administration said on Thursday it had approved Eli Lilly (LLY.N) and partner Boehringer Ingelheim’s drug, Jardiance, for expanded use in reducing the risk o… [read more]

← Prev: Blood cells Damaged by COVID Next: Vascular Disease →